Clark RB - Search Results

1

Identification of a specific domain in the beta-adrenergic receptor required for phorbol ester-induced inhibition of catecholamine-stimulated adenylyl cyclase.

Johnson JA, Clark RB, Friedman J, Dixon RA, Strader CD. Johnson JA, et al. Among authors: clark rb. Mol Pharmacol. 1990 Sep;38(3):289-93. Mol Pharmacol. 1990. PMID: 2169578

2

Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.

Tran TM, Friedman J, Qunaibi E, Baameur F, Moore RH, Clark RB. Tran TM, et al. Among authors: clark rb. Mol Pharmacol. 2004 Jan;65(1):196-206. doi: 10.1124/mol.65.1.196. Mol Pharmacol. 2004. PMID: 14722251

3

Beta(2)-adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for G(s)/G(i) switching.

Friedman J, Babu B, Clark RB. Friedman J, et al. Among authors: clark rb. Mol Pharmacol. 2002 Nov;62(5):1094-102. doi: 10.1124/mol.62.5.1094. Mol Pharmacol. 2002. PMID: 12391272

4

Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.

Clark RB, Allal C, Friedman J, Johnson M, Barber R. Clark RB, et al. Mol Pharmacol. 1996 Jan;49(1):182-9. Mol Pharmacol. 1996. PMID: 8569705

5

Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway.

Seibold A, Williams B, Huang ZF, Friedman J, Moore RH, Knoll BJ, Clark RB. Seibold A, et al. Among authors: clark rb. Mol Pharmacol. 2000 Nov;58(5):1162-73. doi: 10.1124/mol.58.5.1162. Mol Pharmacol. 2000. PMID: 11040066

6

Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.

Johnson JA, Friedman J, Halligan RD, Birnbaumer M, Clark RB. Johnson JA, et al. Among authors: clark rb. Mol Pharmacol. 1991 Oct;40(4):539-46. Mol Pharmacol. 1991. PMID: 1921986

7

Multiple non-specific effects of sphingosine on adenylate cyclase and cyclic AMP accumulation in S49 lymphoma cells preclude its use as a specific inhibitor of protein kinase C.

Johnson JA, Clark RB. Johnson JA, et al. Among authors: clark rb. Biochem J. 1990 Jun 1;268(2):507-11. doi: 10.1042/bj2680507. Biochem J. 1990. PMID: 2163616 Free PMC article.

8

Cell-free heterologous desensitization of adenylyl cyclase in S49 lymphoma cell membranes mediated by cAMP-dependent protein kinase.

Kunkel MW, Friedman J, Shenolikar S, Clark RB. Kunkel MW, et al. Among authors: clark rb. FASEB J. 1989 Jul;3(9):2067-74. doi: 10.1096/fasebj.3.9.2545497. FASEB J. 1989. PMID: 2545497

9

Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase.

Clark RB, Friedman J, Dixon RA, Strader CD. Clark RB, et al. Mol Pharmacol. 1989 Sep;36(3):343-8. Mol Pharmacol. 1989. PMID: 2550773

10

Beta-adrenergic receptor desensitization of wild-type but not cyc lymphoma cells unmasked by submillimolar Mg2+.

Clark RB, Friedman J, Johnson JA, Kunkel MW. Clark RB, et al. FASEB J. 1987 Oct;1(4):289-97. doi: 10.1096/fasebj.1.4.2820824. FASEB J. 1987. PMID: 2820824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters